Intracerebral Hemorrhage Clinical Trials
16 studies are recruiting for intracerebral hemorrhage in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Barrow Neurological Institute, Phoenix, Arizona
- Locations
- 31 in total
- Run by
- Massachusetts General Hospital
-
CoMind Early Feasibility Study
The purpose of this research, which has been determined as non-significant risk by the central IRB overseeing the study, is to obtain information to help further develop a machine (a medical device) to measure the pressure around the brain from the outside (this pressure is called intracranial pres…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UC Davis Medical Center, Sacramento, California
- Locations
- 16 in total
- Run by
- CoMind Technologies Limited
-
Rapid Evacuation and Access of Cerebral Hemorrhage Registry
The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Grady Memorial Hospital, Atlanta, Georgia
- Run by
- Emory University
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is tha…
- Stage
- Phase 3
- Ages
- 18 to 80
- Site
- University of Alabama Hospital, Birmingham, Alabama
- Locations
- 89 in total
- Run by
- Joseph Broderick, MD
-
Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
The principal objective of this study is to compare the incidence of ventriculostomy related infections (VRIs) in patients who receive twenty-four hours of antibiotics, beginning no more than sixty minutes prior to EVD placement, to the incidence of VRIs in patients who also receive a pre-procedura…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Montefiore Medical Center, The Bronx, New York
- Run by
- Montefiore Medical Center
-
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- University of California, Irvine, California
- Locations
- 20 in total
- Run by
- Zeenat Qureshi Stroke Institute
-
Auricular VNS Following Intracerebral Hemorrhage
This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
Improving Outcomes for Patients With Life-Threatening Neurologic Illness
Background: While the intensive care of patients with life-threatening brain illnesses has advanced tremendously, a large number of therapies are still without proper scientific support. This can be partly explained by the fact that mechanisms of initial brain injury are still not well understood. …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Maryland Medical Center, Baltimore, Maryland
- Run by
- University of Maryland, Baltimore
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. Despite this, intensive care and neur…
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- The University of Oklahoma Health, Oklahoma City, Oklahoma
- Locations
- 54 in total
- Run by
- Region Skane
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- University of Alabama Hospital, Birmingham, Alabama
- Locations
- 187 in total
- Run by
- Yale University
-
Evaluating a Prototype CT Scan for ICH Evacuation
The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of th…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mount Sinai West, New York, New York
- Run by
- Icahn School of Medicine at Mount Sinai
-
Statins In Intracerbral Hemorrhage
The SATURN trial aims to determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best strategy; and whether the decision to continue/discontinue statins should be influenced by an individual's Apolipoprotein-E (APOE) genotype.…
- Stage
- Phase 3
- Ages
- 50 and older
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Run by
- Beth Israel Deaconess Medical Center
-
Hemodynamic ABI Monitor
The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Particip…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- University of Chicago, Chicago, Illinois
- Run by
- University of Chicago
-
Augmented Renal Clearance in Neurocritical Care
Stroke, severe brain injury, uncontrolled seizures and brain infections are the most common life-threatening neurological illnesses in the world with an estimated combined annual hospital management cost of up to 44 billion dollars. Seizures and infections are common complications following acute n…
- Stage
- Not phased
- Ages
- 18 to 85
- Site
- UK HealthCare, Lexington, Kentucky
- Locations
- 3 in total
- Run by
- University of Alberta
-
Effect of the Stellate Ganglion Block on the Retinal Microcirculation
Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UT Southwestern Medical Center, Dallas, Texas
- Run by
- University of Texas Southwestern Medical Center
-
Short-term And Longer-term Cognitive Impact Of Neurochecks
The proposed research plan seeks to understand the impact of sleep disruption in the Neurological Intensive Care Unit (ICU) on older patients with acute brain injury (ABI). In current practice, the neurocritical care community performs frequent serial neurological examinations ("neurochecks") in an…
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- UC San Diego Health, San Diego, California
- Run by
- University of California, San Diego
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.